glp 1 fda compounding Out of Shortage, Into Controversy: The Fight Over GLP-1 GLP-1 Medications – FDA Guidance

FDA regulatory context: As of May 2026, the FDA has proposed excluding compounded semaglutide and tirzepatide from the 503B Bulks List, with a public comment period closing June 29, 2026

This equates to 12 ounces of beer (5% alcohol by volume) 5 ounces of wine (12% alcohol by volume) 1.5 ounces or a shot of 80-proof hard liquor (40% alcohol by volume) The Dietary Guidelines for America define moderate drinking as 2 drinks a day or less for men or 1 drink a day or less for women

Dosing is adjusted progressively rather than maximized immediately, which reduces the likelihood of adverse reactions

A: Most preclinical protocols begin with 0.51mg administered orally once daily, observing effects over 714 days before adjusting

Lacour, D